May 28, 2012
Dr. Subrata Ghosh has been approved for induction to Fellowship in the Canadian Academy of Health Sciences (CAHS) and will be formally inducted in Ottawa in September 2012.
The Canadian Academy of Health Sciences provides independent, expert scientific assessments of healthcare science and technology. These assessments are used to inform the public, healthcare providers, and policy makers to promote evidence-informed decision making for the betterment of the health of Canadians.
Fellows elected to the Academy are internationally recognized leaders in health and biomedical science with a commitment to advance health sciences locally, nationally, and internationally through innovation in research and clinical care.
Dr. Subrata Ghosh is a Professor and the Regional Clinical Department Head in the Faculty of Medicine at the University of Calgary. He is also the Fund Development Lead of the Alberta IBD Consortium.
May 23, 2012
Dr. Richard Fedorak and colleagues have developed a urine test to detect pre-cancerous polyps in the colon. Previously this detection has been done by fecal matter tests, which have a low accuracy as well as a low patient compliance rate. Through the detection of metablomic biomarkers in the urine Dr. Fedorak and colleagues identified pre-cancerous polyps with 97% accuracy in a cohort of 1200 patients.
Approximately 1200 people are diagnosed with colon cancer in Alberta every year, and with a mortality rate near 50% early detection is crucial for treatment.
Dr. Fedorak commented, “Since the fecal tests were invented 50 years ago, we haven’t had a new screening test for polyps. This would represent the first new screening test to determine whether there are polyps there in real time. It will fundamentally change the colon cancer screening programs”.
May 4, 2012
We are pleased to congratulate Dr. Kris Chadee in his successful 7-year renewal as a Tier 1 Canada Research Chair in Muscosal Inflammation.
Dr. Chadee’s primary research interests lie in the mechanisms whereby infectious agents, lipid mediators of inflammation and cytokines modulate innate, immune and mucosal epithelial cell functions.
He is a full professor in the Department of Microbiology and Infectious Diseases in the Faculty of Medicine at the University of Calgary and former Chair of the Gastrointestinal Research Group.
May 1, 2012
We are pleased to congratulate Dr. Paul Beck in his receipt of the University of Calgary’s Faculty of Medicine Watanabe Award for Overall Excellence.
Dr. Beck is also the recipient of the 2012 American Gastroenterological Association (AGA) Institute Council Immunology, Microbiology & IBD Section Research Mentor Award.
Dr. Beck’s background as both a clinician and a researcher ideally positions him to bridge the gaps between biomedical research, clinical research, and patient care.
In his own words, “I think that by being a clinician-scientist you can facilitate cutting-edge knowledge translation”.
May 1, 2012
Dr. Derek McKay is the 2011 recipient of the Crohn’s and Colitis Foundation of Canada’s Research Leadership Award.
Dr. McKay joined the University of Calgary in 2006 as a Canada Research Chair and AHFMR Scientist. In addition to receiving multiple CCFC research grants and publishing more than 100 research papers, he has been a CCFC Top Pledge Earner for 11 straight years, supporting the annual Gutsy Walk to raise awareness and money for research.
Dr. McKay is currently using a CCFC grant to study the impact of infection with parasitic worms on intestinal form and function, and inflammatory disease.